Guidelines for diagnostics and treatment of aromatase inhibitor‐induced bone loss in women with breast cancer A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians181. The gene discussed is CYP19A1; the disease is breast cancer.